Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease

Journal of Neural Transmission

Volumn 121, Issue 11, 2014, Pages 1367-1376

  Ding, Yin ^a   Spund, Brian ^b   Glazman, Sofya ^c   Shrier, Eric M ^d,e   Miri, Shahnaz ^c   Selesnick, Ivan ^a,d   Bodis Wollner, Ivan ^c,d,e  

^a POLYTECHNIC UNIVERSITY   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Downstate Health Sciences University   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e SUNY EYE INSTITUTE   (United States)

Author keywords

Fovea; Mathematical modeling; Optical coherence tomography (OCT); Parkinson disease (PD); Retinal imaging

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION MAKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RETINA FOVEA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; FACTUAL DATABASE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; RETINA; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL;

DATABASES, FACTUAL; FEMALE; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PARKINSON DISEASE; RETINA; ROC CURVE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84920511886     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1214-2     Document Type: Article

References (54)

1. Adam CR, Shrier E, Ding A, Bodis-Wollner I, Glazman S (2013) Correlation of inner retinal thickness evaluated by spectraldomain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33(2):137-142
2. Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinsons disease. Doc Ophthalmol 116(2):137-146
3. Bagci AM, Shahidi M, Ansari R, Blair M, Blair NP, Zelkha R (2008) Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 146(5):679-687
4. Bishop CM (2006) Pattern recognition and machine learning. Springer, New York
5. Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 19(1):1-14
6. Bodis-Wollner I, Yahr MD (1978) Measurements of visual evoked potentials in Parkinson's disease. Brain 101(4):661-671
7. Bodis-Wollner I, Glazman S, Yerram S (2013) Fovea and foveation in Parkinson's disease. Behav Neurosci 127(2):139-150
8. Bodis-Wollner I, Miri S, Glazman S (2014) Venturing into the noman's land of the retina in Parkinson's disease. Mov Disord 29(1):15-22
9. Brandt AU, Oberwahrenbrock T, Ringelstein M, Young KL, Tiede M, Hartung HP et al (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(11):e193-e193
10. Budenz DL, Fredette MJ, Feuer WJ, Anderson DR (2008) Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes. Ophthalmology 115(4):661-666
11. Cubo E, Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, Trejo Gabriel Y, Galan JM (2010) Retinal thickness in Parkinson's disease and essential tremor. Mov Disord 25:2461-2462
12. Djamgoz MBA, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37(24):3509-3529
13. Drexler W, Fujimoto JG (2008) State-of-the-art retinal optical coherence tomography. Prog retin eye res 27(1):45-88
14. Dubis AM, McAllister JT, Carroll J (2009) Reconstructing foveal pit morphology from optical coherence tomography imaging. Br J Ophthalmol 93(9):1223-1227
15. Dubis AM, Costakos DM, Subramaniam CD, Godara P, Wirostko WJ, Carroll J, Provis JM (2012) Evaluation of normal human foveal development using optical coherence tomography and histologic examination. Arch Ophthalmol 130(10):1291-1300
16. Dubis AM, Subramaniam CD, Godara P, Carroll J, Costakos DM (2013) Subclinical macular findings in infants screened for retinopathy of prematurity with spectral-domain optical coherence tomography. Ophthalmology 120(8):1665-1671
17. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT (2008) Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49(10):4290-4296
18. Fortune B, Burgoyne CF, Cull G, Reynaud J, Wang L (2013) Onset and progression of peripapillary retinal nerve fiber layer (RNFL) retardance changes occur earlier than RNFL thickness changes in experimental glaucoma. Invest Ophthalmol Vis Sci 54(8):5653-5661
19. Guo L, Duggan J, Cordeiro MF (2010) Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 7(1):3-14
20. Hajee M, March W, Lazzaro D, Wolintz A, Shrier E, Glazman S, Bodis-Wollner I (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737-741
21. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1):29-36
22. Hirsch J, Curcio CA (1989) The spatial resolution capacity of human foveal retina. Vision Res 29(9):1095-1101
23. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG (1991) Optical coherence tomography. Science 254(5035):1178-1181
24. Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 34(19):2629-2638
25. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44(24):2793-2797
26. Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV (2010) Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol 149(3):496-502
27. Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33(1):58-61
28. Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC (2014) Detection of retinal nerve fiber layer defects in Alzheimer's disease using SD-OCT. Front Psychiatry 5:22. doi:10.3389/fpsyt.2014.00022 (Epub ahead of print)
29. Leruez S, Annweiler C, Etcharry-Bouyx F, Verny C, Beauchet O, Milea D (2012) Alzheimer's disease and visual impairment. J Fr Ophtalmol 35(4):308-311
30. Loduca AL, Zhang C, Zelkha R, Shahidi M (2010) Thickness mapping of retinal layers with spectral-domain optical coherence tomography. Am J Ophthalmol 150(6):849855
31. Matlab Statistics Toolbox Release (2011) The MathWorks Inc. Natick, Massachusetts 2011
32. Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with lewy bodies, and Alzheimer's disease. J Alzheimers Dis 34(3):659-664
33. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2010) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24-29
34. Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 10(2):137-144
35. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112(10):1860-1867
36. Provis JM, Hendrickson AE (2008) The foveal avascular region of developing human retina. Arch Ophthalmol 126(4):507-511
37. Provis JM, Diaz CM, Dreher B (1998) Ontogeny of the primate fovea: a central issue in retinal development. Prog Neurobiol 54(5):549-580
38. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69(22):2085-2092
39. Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA (2009) Optical coherence tomography of the retina and optic nerve-a review. Clin Experiment Ophthalmol 37(1):90-99
40. Scheibe P, Lazareva A, Braumann UD, Reichenbach A, Wiedemann P, Francke M, Rauscher FG (2014) Parametric model for the 3D reconstruction of individual fovea shape from OCT data. Exp Eye Res 119:19-26
41. Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I (2012) Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012:728457
42. Sikorski BL, Malukiewicz G, Stafiej J, Lesiewska-Junk H, Raczynska D (2013) The diagnostic function of OCT in diabetic maculopathy. Mediators Inflamm 2013:434560
43. Song WK, Lee SC, Lee ES, Kim CY, Kim SS (2010) Macular thickness variations with sex, age, and axial length in healthy subjects: a spectral domain-optical coherence tomography study. Invest Ophthalmol Vis Sci 51(8):3913-3918
44. Spund BS, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis- Wollner I (2013) Remodeling of the fovea in Parkinson disease. J. Neural Transm 120(5):745-753
45. Stanzione P, Fattapposta F, Tagliati M, D'Alessio C, Marciani MG, Foti A, Amabile G (1990) Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERG-VEP) and cognitive (P300) electrophysiological alterations in Parkinson's disease. Electroencephalogr Clin Neurophysiol Suppl 41:216-220
46. Sung KR, Kim DY, Park SB, Kook MS (2009) Comparison of retinal nerve fiber layer thickness measured by Cirrus HD and Stratus optical coherence tomography. Ophthalmology 116(7):1264-1270
47. Tick S, Rossant F, Ghorbel I, Gaudric A, Sahel JA (2011) Foveal shape and structure in a normal population. Invest Ophthalmol Vis Sci 52(8):5105-5110
48. Tomlins PH, Wang RK (2005) Theory, developments and applications of optical coherence tomography. J Physics D Appl Phys 38(15):2519
49. Tzekov R, Mullan M (2013) Vision function abnormalities in Alzheimer disease. Surv Ophthalmol. doi:10.1016/j.sur vophthal.2013.10.002 (Epub ahead of print)
50. Wagner-Schuman M, Dubis AM, Nordgren RN, Lei Y, Odell D, Chiao H, Weh E, Fischer W, Sulai Y, Dubra A, Carroll J (2011) Race-and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci 52(1):625-634
51. Witkovsky P (2004) Dopamine and retinal function. Documenta ophthalmologica 108(1):17-39
52. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50(7):3432-3437
53. Wollstein G, Ishikawa H, Wang J, Beaton SA, Schuman JS (2005) Comparison of three optical coherence tomography scanning areas for detection of glaucomatous damage. Am J Ophthalmol 139(1):39-43
54. Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F et al (2013) Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol 20(5):803-811